Compare JBS N.V. Class A Common Shares (JBS) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JBS N.V. Class A Common Shares vs Health Care Select Sector SPDR Fund — how do they compare? JBS N.V. Class A Common Shares trades at $13 (market cap $13.96B), while Health Care Select Sector SPDR Fund trades at $176.11 (market cap $43.92B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 3.1× JBS N.V. Class A Common Shares's market cap, and JBS N.V. Class A Common Shares pays a 10.31% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold JBS N.V. Class A Common Shares for 0 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| JBS | XLV | |
|---|---|---|
Market Cap | $13.96B | $43.92B |
Volume | 5,326,589 | 11,816,834 |
Sector | Consumer Staples | — |
52-Week High | $18.42 | $175.68 |
52-Week Low | $10.86 | $142.33 |
Typical Hold Time | 0 Days | 100 Days |
Enterprise Value | $34.93B | — |
Dividend Yield | 10.31% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JBS trades at $12.93, up 0.54% today, with a neutral technical signal and strong analyst buy consensus. The stock shows attractive valuation with a P/E of 12.08 and P/S of 0.47, though recent quarterly EPS misses and a declining profit margin to 1.22% in 2026 highlight earnings pressure. Recent news includes a proposal to acquire full control of Pilgrim's Pride and a joint venture in Southeast Asia, indicating strategic expansion.
The outlook is mixed: analyst targets suggest ~40% upside to $18.17, but risks include execution on acquisitions, margin compression, and volatile beef markets. Cash flow turned positive in 2026 projections, supporting growth initiatives, yet debt levels and competitive pressures warrant caution for investors seeking stability.
XLV trades at $169.66, down 1.35% today, while maintaining a bullish technical outlook with strong moving average signals. The healthcare ETF's low 0.08% expense ratio and diversified exposure to 61 S&P 500 healthcare stocks provide cost-effective sector access. Recent news highlights XLV's defensive characteristics during potential Fed rate hikes and political volatility.
Outlook remains positive given healthcare's defensive positioning amid economic uncertainty, though overbought RSI levels suggest near-term consolidation. Key risks include sector-specific regulatory pressures and election-related policy uncertainty that could impact healthcare stocks through 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About JBS N.V. Class A Common Shares
JBS N.V. is a protein-processing company producing beef, pork, poultry, lamb, fish, and plant-based products, headquartered in São Paulo and Amsterdam. It operates more than 250 production facilities across over 16 countries under brands including Friboi, Seara, Swift, and Pilgrim's, and is the majority shareholder of Pilgrim's Pride Corporation.
Read more on JBS →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
